CFO
Zydus Lifesciences Limited
Equibles does not estimate personal net worth.
Tushar Shroff is recorded as CFO at Zydus Lifesciences Limited. Tushar Shroff has spoken on 1 earnings call across 1 company, most recently for Zydus Lifesciences Limited on August 11, 2026. Zydus Lifesciences Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Yeah, so our current run rate of about, you know, 1,900 to 2,000 crores, I think that kind of a run rate, I think we should assume as a part of the other expenses, excluding R&D on a quarterly basis.”
Zydus Lifesciences Limited
CFO
Transcript header (unverified)
Zydus Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call for the Quarter Ended June 30, 2026
Zydus Lifesciences Limited
